BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KI Science Park - ECPv6.15.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KI Science Park
X-ORIGINAL-URL:https://kisciencepark.se
X-WR-CALDESC:Events for KI Science Park
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260422T113000
DTEND;TZID=Europe/Stockholm:20260422T121500
DTSTAMP:20260417T032657
CREATED:20260205T220502Z
LAST-MODIFIED:20260205T220548Z
UID:10000223-1776857400-1776860100@kisciencepark.se
SUMMARY:BRIDGE Webinar: Preclinical studies
DESCRIPTION:Preclinical studies\n\n\n\nIn this webinar\, LedagoBIO will present key preclinical considerations in drug development\, providing insights into important aspects to address at this stage. \nMore information will come closer to the event. \nRegistration no open yet. \n\nABOUT BRIDGE \nRunning for 3 years and supported by SweLife through the Swedish Innovation Agency\, Vinnova\, BRIDGE aims to create a development platform spanning from identifying drug candidates to production.  Project start: 2024. \nPROJECT PARTNERS \nTesta Center (Project Coordinator): A national “open access” laboratory and production environment for academics and companies looking to verify and upscale their biological process for large-scale production. \nSciLifeLab Drug Discovery and Development Platform (DDD): A national research infrastructure providing state-of-the-art technology and expertise in drug development\, from small molecules\, biological pharmaceuticals\, therapeutic oligonucleotides\, and new modalities\, from concept to preclinical stage. \nStem Cell Center & Pre-GMP Lund University (LU): Conducting research in cell\, tissue\, and gene therapy\, and supporting researchers with pre-GMP services to bridge the gap from research findings to patient care. These units also closely collaborate with the ATMP center (SUS)\, a node for Region Skåne’s work with ATMP treatments. \nSTUNS: Foundation for collaboration between universities in Uppsala\, industry\, and society\, promoting co-creation at the intersection of universities\, industry\, and society to create new opportunities. \nALIS (Association of Life Science Incubators): A national platform that brings together nine regional life science incubators (GU Ventures\, KI Innovations\, Lead\, Medeon\, Sahlgrenska Science Park\, Smile Incubator\, STING\, Umeå Biotech Incubator och Uppsala Innovation Center) tasked with supporting and guiding startups and research groups in skills development\, business development\, coaching\, and access to national and international private capital
URL:https://kisciencepark.se/event/bridge-webinar-preclinical-studies/
LOCATION:Webinar: Microsoft teams
ATTACH;FMTTYPE=image/jpeg:https://kisciencepark.se/wp-content/uploads/2026/02/260422-bridge-webinar.jpg
END:VEVENT
END:VCALENDAR